Physician profile
Sara Robert
NPI 1023002227
$3,867.64
in general payments reported to CMS, 2019-2025
46 companies · $214 in 2025
The $214 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $558 · 2020: $440 · 2021: $963 · 2022: $378 · 2023: $904 · 2024: $410 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,270 · Education: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,270.32 |
| Education | $257.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $570.06 | 2019-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $540.80 | 2019-2025 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $279.66 | 2019-2023 | Injectafer |
| Pfizer INC. | $267.90 | 2019-2023 | |
| Hologic Sales and Service, LLC | $186.63 | 2019-2025 | Aptima, Thinprep 2000 Processor, Novasure |
| Mayne Pharma Commercial LLC | $159.55 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $152.84 | 2020-2021 | |
| Coopersurgical, INC. | $108.71 | 2019-2024 | Paragard T 380a |
| Organon LLC | $102.85 | 2021-2025 | Nexplanon |
| Exeltis, USA INC. | $101.39 | 2020-2024 | Slynd |
| Gynesonics, INC. | $97.45 | 2021 | |
| Lupin INC. | $92.59 | 2019-2021 | |
| Avanos Medical | $89.31 | 2019-2023 | On-Q* Pump and Accessories |
| Evofem Biosciences, INC. | $82.57 | 2021-2025 | Phexxi, Solosec, Phexx |
| Millicent US INC | $79.05 | 2019-2023 | Intrarosa |
Show all 45 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Robert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.